NCT04773717

The Effect of High Dose Parenteral Ascorbic Acid On Microcirculation In Sepsis

The Effect of High Dose Parenteral Ascorbic Acid On Microcirculation In Sepsis. Randomized Double-Blind Placebo-Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Lithuanian University of Health Sciences · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the effect of high-dose ascorbic acid on microcirculation in sepsis.

Detailed description

Adult patients with septic shock were enrolled within 24 hours following admission to the Central Department of Intensive Care in Lithuanian University of Health Sciences Hospital Kaunas Clinics. Participants were randomly assigned to a placebo or ascorbic acid group in a 1:1 ratio. They were resuscitated according to Surviving Sepsis Campaign Guidelines. Additionally, they received an intravenous infusion of ascorbic acid either placebo. The dose of ascorbic acid was 200mg/kg/24h divided into four equal parts for 96 hours. Sublingual microcirculatory measurements were obtained, using an incident dark field (IDF) device.

Conditions

• Sepsis
• Septic Shock

Interventions

Type	Name	Description
DRUG	Ascorbic acid	200mg/kg/24h in four equal parts
DRUG	Placebo	The same regimen as ascorbic acid.

Timeline

• Start date: 2019-01-01
• Primary completion: 2021-01-31
• Completion: 2021-01-31
• First posted: 2021-02-26
• Last updated: 2021-03-03

Locations

1 site across 1 country: Lithuania